RIPE-KG · Version 1.1.0 · Resource

ripekg:work/RIPEW36B4B0D096949384

https://w3id.org/ripe/ripe-kg/work/RIPEW36B4B0D096949384
SubjectPredicateObject
ripekg:work/10.1016%2Fj.hsr.2025.100229Effect of sodium-glucose cotransporter-2 inhibitor on metabolic syndrome in people with prediabetes and obesity: A systematic review and meta-analysis http://purl.org/spar/cito/cites ripekg:work/RIPEW36B4B0D096949384Effect of dapagliflozin administration on metabolic syndrome, insulin sensitivity, and insulin secretion
ripekg:work/RIPEW36B4B0D096949384Effect of dapagliflozin administration on metabolic syndrome, insulin sensitivity, and insulin secretion dcterms:title Effect of dapagliflozin administration on metabolic syndrome, insulin sensitivity, and insulin secretion
ripekg:work/RIPEW36B4B0D096949384Effect of dapagliflozin administration on metabolic syndrome, insulin sensitivity, and insulin secretion rdf:type node1
ripekg:work/RIPEW36B4B0D096949384Effect of dapagliflozin administration on metabolic syndrome, insulin sensitivity, and insulin secretion rdf:type http://purl.org/spar/fabio/Work
ripekg:work/RIPEW36B4B0D096949384Effect of dapagliflozin administration on metabolic syndrome, insulin sensitivity, and insulin secretion rdf:type rdfs:Resource
ripekg:work/RIPEW36B4B0D096949384Effect of dapagliflozin administration on metabolic syndrome, insulin sensitivity, and insulin secretion rdf:type owl:Thing
ripekg:work/RIPEW36B4B0D096949384Effect of dapagliflozin administration on metabolic syndrome, insulin sensitivity, and insulin secretion rdf:type prov:Entity
ripekg:work/RIPEW36B4B0D096949384Effect of dapagliflozin administration on metabolic syndrome, insulin sensitivity, and insulin secretion rdf:type ripe:WorkWork